Amarantus BioScience Holdings, Inc.

AMBS · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$4,762-$10,196-$628$18,377
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$241$269$545-$17,360
Other Non-Cash$22$0$0$0
Operating Cash Flow-$4,499-$9,927-$83$1,017
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$2,026
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4,499$9,973-$81$0
Investing Cash Flow$4,499$9,973-$81-$2,026
Financing Activities
Debt Repay.$0$0$63$913
Stock Issued$0$2$11$38
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$47$89$58
Financing Cash Flow$0-$45$163$1,009
Forex Effect$0$0$0$0
Net Chg. in Cash-$1$1-$1-$0
Supplemental Information
Beg. Cash$1$0$1$1
End Cash$0$1$0$1
Free Cash Flow-$4,499-$9,927-$83$1,017